When you think about it if the board goal was to sell down would you have chosen the experience of CM? Why would you sell down a possible income producing asset at probably it's lowest point if you could afford $ to turn it around and it is possibly the nearest term asset with lowest barriers if they just play by the system and don't IMO lawyer at every turn. Then sell it down at a reasonable point in time if a offer exceeds IRR. Not sure what can be said in a webinar unless they actually are forthcoming with what internal review has provided in term of a direction. The most likely and usual MO for new CEO is to throw out the trash and blame the previous CEO ( A little hard when she is still on tether?) and then start a new focus / direction and try and get new holders to table that have that vision.
Again when looking at experience and history doe sit look like CM is that person? Not sure and hard to tell if the board has IMO drunk the coolaide and believed they were ready to have late stage research and able to partner and head to lic style agreements which CM has background in but key background iMO was in large company supported was progressing finished late stage drugs to market with a massive support network and totally different to little old SPL. So unless the "the partner" is going to provide all that support it is a odd mix but of course CM ma be a dark horse in terms of effective management but INO it would be a massive step to achieve in SPL entrenched structure. I was hoping to see some action by now but maybe things internally are harder to sort wheat from chaff and navigate politics. If no clear direction and timelines are set at this one off opportunity every incoming CEO has IMO it won't be a good outcome. Longer she leaves it is no problem as long as result is a clear plan aid stages can be seen as being achieved by shareholders. IMO she can't wait forever for some " good news" to hide throwing out of trash and come clean moment so at some point it just has to happen ( assuming there is trash to dispose of)
All guesswork as to date so little communication and progress reported shareholders don't really know what pathways are being followed as a priority. Timeline for medexi is long term so hard to add short term value IMo and more of a hail mary IMO but some movement
